Blanchard AC, Waters VJ (2019) Microbiology of cystic fibrosis airway disease. Semin Respir Crit Care Med 40:727–736. https://doi.org/10.1055/s-0039-1698464
Article PubMed PubMed Central Google Scholar
Jurado-Martín I, Sainz-Mejías M, McClean S (2021) Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci 22:1–37
Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539–574. https://doi.org/10.1111/j.1365-2672.2007.03706.x
Article CAS PubMed PubMed Central Google Scholar
Pritt B, O’Brien L, Winn W (2007) Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol 128:32–34. https://doi.org/10.1309/KJRPC7DD5TR9NTDM
Li Z, Kosorok MR, Farrell PM et al (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293:581–588
Article CAS PubMed Google Scholar
Talwalkar JS, Murray TS (2016) The Approach to Pseudomonas aeruginosa in Cystic Fibrosis. Clin Chest Med 37:69–81. https://doi.org/10.1016/j.ccm.2015.10.004
Clark ST, Diaz Caballero J, Cheang M et al (2015) Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Sci Rep 5:10932. https://doi.org/10.1038/srep10932
Article CAS PubMed PubMed Central Google Scholar
Høiby N, Ciofu O, Bjarnsholt T (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5:1663–1674. https://doi.org/10.2217/fmb.10.125
Tai AS, Sherrard LJ, Kidd TJ et al (2017) Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis. BMC Pulm Med 17:1–10. https://doi.org/10.1186/s12890-017-0482-7
Malhotra S, Hayes D, Wozniak DJ (2019) Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung. J Cyst Fibros 18:796–803. https://doi.org/10.1016/j.jcf.2019.04.009
Article CAS PubMed PubMed Central Google Scholar
Malhotra S, Limoli DH, English AE et al (2018) Mixed communities of mucoid and nonmucoid pseudomonas aeruginosa exhibit enhanced resistance to host antimicrobials. mBio. 9:1–15. https://doi.org/10.1128/mBio
Goddard M (2011) Histopathology of bronchiectasis. Bronchiectasis. https://doi.org/10.1183/1025448x.10003310
Dasenbrook EC, Lu L, Donnola S et al (2013) Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients—a cross-sectional study. PLoS ONE 8:1–7. https://doi.org/10.1371/journal.pone.0073286
Li Z, Sanders DB, Rock MJ et al (2012) Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatr Pulmonol 47:635–640. https://doi.org/10.1002/ppul.21604
Wyckoff TJO, Thomas B, Hassett DJ, Wozniak DJ (2002) Static growth of mucoid Pseudomonas aeruginosa selects for non-mucoid variants that have acquired flagellum-dependent motility. Microbiology (N Y) 148:3423–3430. https://doi.org/10.1099/00221287-148-11-3423
Ciofu O, Lee B, Johannesson M et al (2008) Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology (N Y) 154:103–113. https://doi.org/10.1099/mic.0.2007/010421-0
Govan JRW, Fyfe JAM, McMillan C (1979) The instability of mucoid pseudomonas aeruginosa: fluctuation test and improved stability of the mucoid form in shaken culture. J Gen Microbiol 110:229–232
Article CAS PubMed Google Scholar
Dubin PJ, Kolls JK (2007) IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 292:L519–L528. https://doi.org/10.1152/ajplung.00312.2006
Article CAS PubMed Google Scholar
Ribeiro CMP, Higgs MG, Muhlebach MS et al (2023) Revisiting host-pathogen interactions in cystic fibrosis lungs in the era of CFTR modulators. Int J Mol Sci 24(5):5010
Article CAS PubMed PubMed Central Google Scholar
Gifford AH, Matsuoka M, Ghoda LY et al (2012) Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes. Mucosal Immunol 5:480–484
Article CAS PubMed Google Scholar
Lammertyn EJ, Vandermeulen E, Bellon H et al (2017) End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis. Respir Res 18:1–9. https://doi.org/10.1186/s12931-016-0489-2
Sajjan U, Corey à M, Humar]}}});">Buy article PDF 39,95 €
留言 (0)